Global Influenza Diagnostics Market Research Report - Global Forecast To 2023

Global Influenza Diagnostics Market Research Report - Global Forecast To 2023

ID: MRFR/HC/2264-HCRR | July, 2017 | Region: Global | 88 pages | Half-Cooked Research Reports

Global Influenza Diagnostics Market information, by type of flu (Type A flu, type B flu, Type C flu), by Test type (Molecular Tests, Rapid Influenza Detection Tests (RIDT), Direct Fluorescent Antibody (DFA) Tests, Nucleic Acid Sequence-based Amplification (NASBA) Tests, Serological Assays, Simple Amplification-based Assays (SAMBA), Loop-mediated Isothermal Amplification-based Assays (LAMP), and Others), by End User ( Hospital and clinics, Research laboratories, Educational institutions, and others) - Forecast to 2023


Study objectives of Global Influenza Diagnostics Market:



  • To provide detailed analysis of the Global Influenza Diagnostics market structure with historical and forecasted revenue for the next 6 years of the various segments and sub-segments of the influenza diagnostics Market

  • To provide insights about the key drivers, restraints, opportunities and challenges that affecting the growth of the Influenza Diagnostics market

  • To provide analysis of the market with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide detail analysis of the market that segmented on the basis of type of flue, test type, by end user, and its sub-segments.

  • To provide detail analysis of global Influenza Diagnostics market mainly based on Value chain analysis, Porter’s five forces, Price analysis, and Supply Chain analysis etc.

  • To provide detail country level analysis of the market with respect to the current market size and future prospective

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Influenza Diagnostics Market

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market


FIGURE 1                   GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY END USER


 GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY END USER


Sources: WHO, National Foundation for Infectious Diseases, Directorate of Industries, Annual report, White paper, Company Presentation


Intended Audience



  • Influenza Diagnostics Solution providers

  • Diagnostic suppliers

  • Medical Research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology:
Research Methodology Influenza Diagnostics Market


 Sources: WHO, National Foundation for Infectious Diseases, Directorate of Industries, Annual report, White paper, Company Presentation


Market Synopsis of Global Influenza Diagnostics Market:


Market Scenario:


Global Influenza Diagnostics Market is growing moderately. Influenza or flu is one of the common medical condition which occur in seasonal epidemics and shows an acute illness with variable degrees of systemic symptoms which ranges from mild fatigue to respiratory failure and death. Influenza B is most common type of flu. Influenza infection can create health complications which may be deadly, but early diagnosis of influenza can reduces the chances of further complications. According the World Health organization, there are almost 600 million cases of influenza worldwide. The increasing demand for advanced diagnostic products and kits, increasing R&D funding for new innovative products and increasing healthcare expenditure are major driving factors for this market. The Global Influenza Diagnostics market is expected to reach US$ 700.7 million by 2023 and is projected to grow at the CAGR of ~5.8% during the forecast period from 2017-2023.


Segments:                                                                                                                                        


Global Influenza Diagnostics Market has been segmented on the basis of type of flu which comprise Type A flu (Seasonal flu, Swine Flu, Bird Flu), type B flu, Type C flu. On the basis of type of test it segmented into Molecular Tests, Rapid Influenza Detection Tests (RIDT), Direct Fluorescent Antibody (DFA) Tests, Nucleic Acid Sequence-based Amplification (NASBA) Tests, Serological Assays, Simple Amplification-based Assays (SAMBA), Loop-mediated Isothermal Amplification-based Assays (LAMP), and Others. Serological assays further sub segmented into Primary Serological tests (Enzyme linked immunosorbent assay (ELISA), Immuno fluorescent antibody technique (IFAT), Radio immuno assay (RIA), Secondary Serological tests (Agglutination tests, Complement fixation tests (CFT), Precipitation tests, Serum neutralization tests (SNT), Toxin-antitoxin test), and Tertiary serological tests.


Regional Analysis of Global Influenza Diagnostics Market:                  


Considering the global scenario of the market, North America is believed to be the largest market for Global Influenza Diagnostics due to advanced healthcare facilities and increasing presence of major players in this region. Moreover, the European market second largest market for Global Influenza Diagnostics. In Europe, Western Europe accounts the largest market share. While Asia-Pacific is expected to grow at significant rate in the Global Influenza Diagnostics market during the forecasted period. Middle East and Africa is likely to have a limited growth in the market due to less awareness of these therapies and treatment.  


Key Players for Global Influenza Diagnostics Market:                               


Some of the key players in this market are: Alere (US), BD (US), Becton, Dickinson and Company (U.S.), Cepheid (US), bioMérieux SA (France), Hardy Diagnostics(us), LifeSign LLC.(US), Meridian Bioscience, Inc.(US), Quidel Corporation (US), Roche Molecular Systems Inc.(Switzerland), Sekisui Diagnostics (US)


The report for Global Influenza Diagnostics Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions


 

1.         Report Prologue

2.         Introduction

2.1       Definition

2.2       Scope of the Study

2.2.1    Research Objective

2.2.2    Assumptions

2.2.3    Limitations

2.3       Market Structure

2.4.      Market Segmentation

3.         Research Methodology

3.1       Research Process

3.2       Primary Research

3.3       Secondary Research

3.4       Market Size Estimation

3.5       Forecast Model

4.         Market Dynamics

4.1       Drivers

4.2       Restraints

4.3       Opportunities

4.4       Mega Trends

4.5       Macroeconomic Indicators

5.         Market Factor Analysis

5.1       Value Chain Analysis

5.2       Porters Five Forces

5.3       Demand & Supply: Gap Analysis

5.4       Pricing Analysis

5.5       Investment Opportunity Analysis

5.6       Merger and Acquisition Landscape

5.7       Upcoming trends

5.7.1    Market trends

5.7.2    Technological trends

5.7.3    Insurance & Regulations

5.7.4    Others

6.         Global Influenza Diagnostics Market by Type of Flu

6.1       Type A flu

            6.1.1    Seasonal Flu

6.1.2    Swine Flu

6.1.3    Bird Flu

6.2       type B flu

6.3       Type C flu

7.         Global Influenza Diagnostics Market by Test Type

7.1       Molecular Tests,

7.2       Rapid Influenza Detection Tests (RIDT)

7.3       Direct Fluorescent Antibody (DFA) Tests

7.4       Nucleic Acid Sequence-based Amplification (NASBA) Tests

7.5       Serological Assays

            7.5.1    Primary Serological tests

                        7.5.1.1 Enzyme Linked ImmunoSorbent Assay (ELISA)

7.5.1.2 Immuno Fluorescent Antibody Technique (IFAT)

7.5.1.3 Radio Immuno Assay (RIA)

            7.5.2    Secondary Serological tests

                        7.5.2.1 Agglutination tests

7.5.2.2 Complement fixation tests (CFT)

7.5.2.3 Precipitation tests

7.5.2.4 Serum Neutralization Tests (SNT)

7.5.2.5 Toxin-antitoxin test

            7.5.3    Tertiary serological tests

7.6       Simple Amplification-based Assays (SAMBA)

7.7       Loop-mediated Isothermal Amplification-based Assays (LAMP),

7.8       Others

8.         Global Influenza Diagnostics Market by Region

8.1       Introduction

8.2       America

8.2.1    North America

8.2.1.1 The US

8.2.1.2 Canada

8.2.2    South America

8.3       Europe

8.3.1    Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.3 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2    Eastern Europe

8.4       Asia

8.4.1    China

8.4.2    India

8.4.3    Japan

8.4.4    South Korea

8.4.5    Rest of Asia

8.5       Pacific

8.6       Middle East and Africa

8.6.1    UAE

8.6.2    Saudi Arabia

8.6.3    Egypt

8.6.4    Rest of Middle East and Africa

9          Conclusion

9.1       Key findings

9.1.1    From CEO’s viewpoint

9.1.2    Unmet needs of the market

9.2       Key companies to watch

9.3       Prediction of medical robots industry

10        Appendix